---
id: biotech-and-genomics
name: BioTech & Genomics
family: technological
tier: active
url: https://explorer.talin.digital/e/biotech-and-genomics/
author: Benjamin Talin
citation: Talin, B. (2026). The Future Explorer. https://explorer.talin.digital (dataset v0.4.0, 2026-11-16)
license: CC-BY-NC-4.0
---

# BioTech & Genomics

Reading, understanding and editing the instructions inside living things, their DNA. Reading a whole human genome cost about $95 million in 2001 and about $525 two decades later, a faster fall than computer chips ever managed. That cheap reading powers new tests and medicines. Fixing what we read is far slower: the first gene-editing cure for sickle cell disease had reached only a few dozen patients worldwide almost two years after approval.

> Reading, interpreting and editing biological information - genome sequencing, the diagnostics built on it, and the gene therapies that act on it.

## Maturity
3/5 — Reading a genome is cheap and routine - about $525 at NHGRI's last measurement. Acting on it is not: almost two years after approval, the first CRISPR medicine had been infused into 39 patients worldwide. The score is the slower of the two.

Capability 5 · deployment 3 · absorption 3 · bound by capital · flat

Source: NHGRI Genome Sequencing Program cost data (Wetterstrand; last point May 2022, page updated 16 May 2023); FDA (8 Dec 2023); CRISPR Therapeutics Q3 2025 results (10 Nov 2025, company-reported); Orchard Therapeutics (20 Mar 2024) (2001–2025)

## What it is
Reading, interpreting and applying biological information - sequencing, diagnostics, and the biological engineering built on them.

## What it does
It converted biology from an observational science into an engineering one. Sequencing cost fell faster than semiconductor cost over the same period, which is the sharpest exponential in this book.

## Common misconception
That falling sequencing cost translates into clinical benefit at the same rate. Interpretation, evidence generation and clinical integration are each far slower, and each is the binding constraint somewhere.

## Steepens
- Longevity and the Healthspan Gap (longevity-and-the-healthspan-gap) — large
- Precision Everything (precision-everything) — large
- Zoonotic and Antimicrobial Resistance Risk (zoonotic-and-antimicrobial-resistance-risk) — moderate
- Food System Transformation (food-system-transformation) — moderate

## What would change its gradient
- Interpretation at population scale, which requires diverse reference data
- Clinical evidence generation, which runs on trial timescales
- Reimbursement, which decides what reaches patients
